One of the major strengths of the present study was our ability to assess the treatment response and side effects of atomoxetine therapy in Chinese children with ADHD by integrating TDM and CYP2D6 genetic testing. Here, CYP2D6 is linked to attention deficit-hyperactivity disorder.